These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 3756879
1. Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas. Shiloh Y, Korf B, Kohl NE, Sakai K, Brodeur GM, Harris P, Kanda N, Seeger RC, Alt F, Latt SA. Cancer Res; 1986 Oct; 46(10):5297-301. PubMed ID: 3756879 [Abstract] [Full Text] [Related]
2. [Oncogene amplification in human neuroblastomas]. Kanda N, Tsuchida Y, Hayashi Y, Ise T, Takayama J, Utakoji T. Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):661-6. PubMed ID: 3963837 [Abstract] [Full Text] [Related]
3. Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines. Tonin PN, Yeger H, Stallings RL, Srinivasan PR, Lewis WH. Oncogene; 1989 Sep; 4(9):1117-21. PubMed ID: 2780050 [Abstract] [Full Text] [Related]
5. Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells. Corvi R, Savelyeva L, Schwab M. Cancer Res; 1995 Aug 15; 55(16):3471-4. PubMed ID: 7627947 [Abstract] [Full Text] [Related]
6. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group. George RE, Kenyon RM, McGuckin AG, Malcolm AJ, Pearson AD, Lunec J. Oncogene; 1996 Apr 04; 12(7):1583-7. PubMed ID: 8622876 [Abstract] [Full Text] [Related]
7. Multiple amplicons of discrete sizes encompassing N-myc in neuroblastoma cells evolve through differential recombination from a large precursor DNA. Amler LC, Schwab M. Oncogene; 1992 Apr 04; 7(4):807-9. PubMed ID: 1565478 [Abstract] [Full Text] [Related]
8. High-resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas. Reiter JL, Brodeur GM. Genomics; 1996 Feb 15; 32(1):97-103. PubMed ID: 8786126 [Abstract] [Full Text] [Related]
9. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma]. Kniazev PG, Schafer R, Willecke K, Pluzhnikova GF, Serova OM. Mol Biol (Mosk); 1986 Feb 15; 20(5):1236-43. PubMed ID: 3022123 [Abstract] [Full Text] [Related]
10. myc gene amplification and expression in primary human neuroblastoma. Slavc I, Ellenbogen R, Jung WH, Vawter GF, Kretschmar C, Grier H, Korf BR. Cancer Res; 1990 Mar 01; 50(5):1459-63. PubMed ID: 2302711 [Abstract] [Full Text] [Related]
11. Analysis of a novel locus frequently co-amplified with N-myc in human neuroblastoma. Montgomery KT, Melera PW. Prog Clin Biol Res; 1988 Mar 01; 271():71-88. PubMed ID: 3406025 [No Abstract] [Full Text] [Related]
12. Yeast artificial chromosome (YAC) vector cloning of the MYCN amplified domain in neuroblastomas. Schneider SS, Zehnbauer BA, Vogelstein B, Brodeur GM. Prog Clin Biol Res; 1991 Mar 01; 366():71-6. PubMed ID: 2068181 [Abstract] [Full Text] [Related]
13. Differential amplification, assembly, and relocation of multiple DNA sequences in human neuroblastomas and neuroblastoma cell lines. Shiloh Y, Shipley J, Brodeur GM, Bruns G, Korf B, Donlon T, Schreck RR, Seeger R, Sakai K, Latt SA. Proc Natl Acad Sci U S A; 1985 Jun 01; 82(11):3761-5. PubMed ID: 3858848 [Abstract] [Full Text] [Related]
14. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study. Cohn SL, Look AT, Joshi VV, Holbrook T, Salwen H, Chagnovich D, Chesler L, Rowe ST, Valentine MB, Komuro H. Cancer Res; 1995 Feb 15; 55(4):721-6. PubMed ID: 7850780 [Abstract] [Full Text] [Related]
15. Characterization of a complex genomic alteration on chromosome 2p that leads to four alternatively spliced fusion transcripts in the neuroblastoma cell lines IMR-5, IMR-5/75 and IMR-32. Oberthuer A, Skowron M, Spitz R, Kahlert Y, Westermann F, Mehler K, Berthold F, Fischer M. Gene; 2005 Dec 19; 363():41-50. PubMed ID: 16216448 [Abstract] [Full Text] [Related]
16. Amplification of IMR-32 clones 8, G21, and N-myc in human neuroblastoma xenografts. Kanda N, Tsuchida Y, Hata J, Kohl NE, Alt FW, Latt SA, Utakoji T. Cancer Res; 1987 Jun 15; 47(12):3291-5. PubMed ID: 3034408 [Abstract] [Full Text] [Related]
17. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma. Cohn SL, Rademaker AW, Salwen HR, Franklin WA, Gonzales-Crussi F, Rosen ST, Bauer KD. Am J Pathol; 1990 May 15; 136(5):1043-52. PubMed ID: 2349963 [Abstract] [Full Text] [Related]
18. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification. Cheng JM, Hiemstra JL, Schneider SS, Kaufman BA, Naumova A, Cheung NK, Cohn SL, Diller L, Sapienza C, Brodeur GM. Prog Clin Biol Res; 1994 May 15; 385():43-9. PubMed ID: 7972236 [Abstract] [Full Text] [Related]
19. Increased N-myc expression following progressive growth of human neuroblastoma. Rosen N, Reynolds CP, Thiele CJ, Biedler JL, Israel MA. Cancer Res; 1986 Aug 15; 46(8):4139-42. PubMed ID: 3731081 [Abstract] [Full Text] [Related]
20. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation. Raschella G, Romeo A, Negroni A, Pucci S, Dominici C, Castello MA, Bevilacqua P, Felsani A, Calabretta B. Cancer Res; 1994 Apr 15; 54(8):2251-5. PubMed ID: 8174135 [Abstract] [Full Text] [Related] Page: [Next] [New Search]